Eva Maria Galan-Moya left the lab
Eva Maria Galan-Moya has been a post-doc for 5 years with us. She is now back in Spain. Good luck!
Julie's lecture at 2nd International Symposium on Cancer and Inflammation: Valdivia, Chile
vascular permeability in brain tumors http://www.inmunoterapia.cl/Symposium-Valdivia-2015/
Control of CXCR2 activity through its ubiquitination on K327 residue
Control of CXCR2 activity through its ubiquitination on K327 residue. The K327 residue on human CXCR2 (IL-8 high affinity receptor) was...